Overall rank by patents
#345
Across all tracked assignees
USPTO PatentsView assignee record - 1,245 granted patents across 56 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
Synopsys holds 1,245 US patents across 56 technology areas, rank #345 of 50,000 tracked assignees.
Synopsys, Inc. has been granted 1,245 US utility patents between 2015 and 2025, placing Synopsys, Inc. at rank #345 across all assignees tracked by PlainPatent. This portfolio spans 56 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.0 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a US Corporation, Synopsys, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Synopsys sits between The Trustees Of The University Of Pennsylvania (1,264 patents, rank #341) and HKC Corporation Limited (1,232 patents, rank #349) - the closest US assignees by grant volume. The composite Innovation Score of 67.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 670 grants, compared with 575 in the 2015–2019 window, a +17% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Synopsys, Inc.'s 20.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 56 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Synopsys, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
The Trustees of the University of Pennsylvania
1,264 patents
Terumo Kabushiki Kaisha
1,250 patents
Empire Technology Development LLC
1,248 patents
Merck Sharp & Dohme LLC
1,248 patents
SYNOPSYS, INC.
1,245 patents
Symantec Corporation
1,244 patents
FCA US LLC.
1,243 patents
Philip Morris Products S.A.
1,240 patents
HKC CORPORATION LIMITED
1,232 patents
What this shows Synopsys holds 1,245 patents at rank #345, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #345 in granted patent volume.
Other assignees with the most granted patents in Synopsys's primary technology class.
Synopsys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
67 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 119 | 9.6% |
| 2016 | 107 | 8.6% |
| 2017 | 108 | 8.7% |
| 2018 | 88 | 7.1% |
| 2019 | 153 | 12.3% |
| 2020 | 133 | 10.7% |
| 2021 | 98 | 7.9% |
| 2022 | 94 | 7.6% |
| 2023 | 116 | 9.3% |
| 2024 | 126 | 10.1% |
| 2025 | 103 | 8.3% |
Top 15 of 56 technology areas
Overall rank by patents
#345
Across all tracked assignees
67.4 out of 100
How to use this portfolio
Synopsys's 1,245 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.